The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Addiction psychiatry is a medical specialty that focuses on the assessment, diagnosis, and treatment of individuals who are struggling with substance use disorders or other addictive behaviors. In recent years, there has been a significant increase in opioid overdose deaths, leading to a public health crisis. One recent study found that medication-assisted treatment with buprenorphine was associated with a 40% reduction in overdose deaths among people with opioid use disorders. This sessions will cover a variety of addiction psychiatry subtopics, it is not an exhaustive list and there are many other important areas of research and practice within this field.
- Track 1-1 Substance use disorder
- Track 1-2 Behavioural addictions
- Track 1-3 Medication assisted treatment
- Track 1-4 Dual diagnosis
- Track 1-5 Public health policy and systems
Addiction and Neuroscience is a field of study that investigates the neural mechanisms that underlie addiction and substance use disorders. It focuses on understanding how the brain is affected by drugs of abuse and how these changes contribute to the development and maintenance of addiction Recent research in Addiction and Neuroscience has made significant contributions to our understanding of the neural mechanisms underlying addiction and substance use disorders. Researchers have identified specific neural circuits involved in addiction, including the mesolimbic dopamine system, which plays a key role in reward processing and addiction.
- Track 2-1 Drug Reward
- Track 2-2 Dopamine and Neuroplasticity
- Track 2-3 Neurocircuitry and Addiction
- Track 2-4 Interoceptive Awareness
- Track 2-5 Neuroimaging
Addiction medicine is a rapidly growing field, and it's essential for healthcare professionals to stay up-to-date on the latest research and best practices. Research has shown that integrating addiction treatment into primary care settings can improve access to care and patient outcomes. This includes providing medication-assisted treatment (MAT) for opioid use disorder in primary care settings, as well as screening and brief interventions for other substances. This session will provide an overview of the different types of addiction and their prevalence rates.
- Track 3-1 Screening and brief interventions
- Track 3-2 Medication-assisted treatment (MAT)
- Track 3-3 Co-occurring mental health condition
- Track 3-4 Motivational interviewing
- Track 3-5 Addressing health disparities
Addiction to drugs and substance abuse are complex issues that can have significant negative impacts on an individual's physical and mental health, social relationships, and overall well being. A 2021 study published in the Journal of Substance Abuse Treatment found that the COVID-19 pandemic led to increased stress and substance use among individuals with substance use disorders, highlighting the need for continued access to addiction treatment during public health emergencies. This session will examine the different treatment approaches for addiction and explore the challenges of maintaining long-term treatment success.
- Track 4-1 Neurobiology of addiction
- Track 4-2 Risk factors for addiction
- Track 4-3 Diagnosis and assessment of addiction
- Track 4-4 Treatment approaches for addiction
- Track 4-5 Prevention of addiction
Addiction and substance use during pregnancy is a significant public health concern as it can have serious consequences for both the mother and the developing fetus. Recent research has shown that opioid use during pregnancy has increased dramatically in recent years, and this increase has been associated with a rise in neonatal abstinence syndrome (NAS). Research has also highlighted the importance of providing comprehensive care for pregnant women with substance use disorders, including access to prenatal care, substance abuse treatment, and social services. session could provide information and resources for healthcare providers, social workers, and other professionals who work with pregnant women who struggle with addiction and substance use. The goal would be to increase understanding of the risks and challenges associated with addiction and substance use during pregnancy.
- Track 5-1 Neonatal abstinence syndrome (NAS)
- Track 5-2 Pharmacological treatment
- Track 5-3 Pharmacological treatment
- Track 5-4 Mental health
- Track 5-5 Health disparities
Adolescent addiction and at-risk substance use are important public health issues that can have serious short-term and long-term consequences for young people. Here is an overview of some key aspects of adolescent addiction and adolescent addiction refers to the compulsive use of drugs or alcohol despite negative consequences. Recent research highlights the complex nature of adolescent addiction and at-risk use, and emphasizes the importance of addressing multiple factors, such as family dynamics, mental health, and social media use. This sessions will cover related subtopics, healthcare providers, educators, and parents can better identify and address the specific challenges facing adolescents who struggle with addiction and at-risk use.
- Track 6-1 Opioid epidemic
- Track 6-2 Vaping and e-cigarettes
- Track 6-3 Marijuana use
- Track 6-4 Trauma and adverse childhood experiences
- Track 6-5 Racial and ethnic disparities
Alcoholism and drug addiction are chronic diseases characterized by compulsive drug-seeking and use despite the harmful consequences. They are considered a major public health concern, affecting individuals and communities worldwide. Researchers have identified several genes that are associated with increased risk of addiction, including those involved in the reward pathway in the brain. This session will provide an overview of several key topics related to alcoholism and drug addiction. The neurobiology and genetics of addiction will be explored, including how changes in brain structure and function can contribute to addictive behaviors.
- Track 7-1 Neurobiology and genetics of addiction
- Track 7-2 Co-occurring disorders and dual diagnosis
- Track 7-3 Pharmacotherapy for addiction
- Track 7-4 Behavioral therapies for addiction
- Track 7-5 Prevention of addiction
The pharmacology of drug addiction involves the study of how drugs of abuse interact with the brain and body to produce addictive behaviors. Recent research in the pharmacology of drug addiction, published in the journal Nature Communications found that a specific protein, known as RGS7, may play a key role in regulating opioid receptor signalling in the brain. This sessions will cover a important aspects of the pharmacology of drug addiction. By understanding the neurobiological processes underlying addiction, individual differences in drug responses, and the pharmacokinetics of drugs of abuse, researchers can develop more effective medications for addiction treatment.
- Track 8-1 Drug tolerance and withdrawal
- Track 8-2 Medications for addiction treatment
- Track 8-3 Drug pharmacokinetics
- Track 8-4 Individual differences in drug responses
- Track 8-5 Neurotransmitter systems
Alcohol addiction, also known as alcohol use disorder (AUD), is a chronic disease characterized by a compulsive and uncontrollable need to consume alcohol despite the negative consequences it may have on a person's physical health, mental well-being, and social functioning. Research has shown that chronic alcohol use can lead to changes in the brain's reward system and decision-making processes, which can contribute to the development of addiction. This session will cover the potentially dangerous condition of alcohol withdrawal, including symptoms, risk factors, and treatment options. Participants will learn how to recognize alcohol withdrawal and how to provide appropriate medical care for patients experiencing withdrawal.
- Track 9-1 Alcohol withdrawal
- Track 9-2 Dual diagnosis
- Track 9-3 Alcohol-related liver disease
- Track 9-4 Underage drinking
- Track 9-5 Harm reduction
Food addiction refers to a behavioral addiction characterized by a compulsion to consume high-calorie, high-fat, and/or high-sugar foods. It is a type of addiction that is similar to drug and alcohol addiction, in that individuals experience a loss of control over their food. Recent research on food addiction has focused on various aspects, including the underlying neural mechanisms, psychological factors, and potential treatments. One recent study published in the journal Obesity Reviews found evidence that sugary and high-fat foods can trigger brain reward pathways and lead to addictive-like eating behaviors in some individuals. This session will focus on the development of effective interventions for food addiction. It may explore the use of pharmacological and non-pharmacological treatments.
- Track 10-1 Neurobiology of food addiction
- Track 10-2 Behavioral patterns and food addiction
- Track 10-3 Diagnosis and measurement of food addiction
- Track 10-4 Treatment of food addiction
- Track 10-5 Obesity and food addiction
Social media addiction refers to the excessive and compulsive use of social media platforms such as Facebook, Twitter, Instagram, Snapchat, and others. It is a relatively new area of research, but studies have shown that social media addiction can have negative impacts on mental health, including increased anxiety, depression, and loneliness. A 2021 study published in the Journal of Social and Clinical Psychology found that excessive social media use was associated with higher levels of anxiety and depression among young adults. The study also found that reducing social media use led to improvements in mental health. Diagnostic criteria for social media addiction This session will explore the relationship between social media addiction and cognitive function, including attentional control, memory, and decision-making.
- Track 11-1 The psychology of social media addiction
- Track 11-2 The impact of social media addiction on mental health
- Track 11-3 Social media addiction and cognitive function
- Track 11-4 Social media addiction treatment
Pain and addiction are two complex issues that are often interconnected. Pain is a common experience for many people and can be caused by a variety of factors, including injury, illness, or chronic conditions. Recent research has shed light on the complex relationship between pain and addiction, and has highlighted the need for more effective approaches to pain management and addiction treatment can be so severe and chronic that it becomes debilitating and interferes with daily functioning. This session will cover a healthcare providers can gain a better understanding of the complex relationship between pain and addiction, and the range of approaches available for managing pain and preventing addiction.
- Track 12-1 Medication-assisted treatment for addiction
- Track 12-2 Prescription drug monitoring program
- Track 12-3 Alternative pain management approaches
- Track 12-4 Chronic pain management
- Track 12-5 Opioid overdose prevention
Child and Adolescent Psychiatry is a specialized field of psychiatry that focuses on the diagnosis, treatment, and prevention of mental health disorders in children and adolescents. With the increasing prevalence of technology in children's and adolescents' lives, research will continue to explore the potential benefits and risks of technology-based interventions for mental health. The Child and Adolescent Psychiatry session would aim to provide an overview of these disorders and their impact on children and adolescents. It may also cover evidence-based treatments and strategies for managing and treating these disorders to improve the mental health and wellbeing of affected children and adolescents.
- Track 13-1 Developmental disorder
- Track 13-2 Psychotic disorders
- Track 13-3 Personality disorders
- Track 13-4 Neurodevelopmental disorders
- Track 13-5 Behavioral and conduct disorders
Clinical psychiatry is a branch of medicine that specializes in the diagnosis, treatment, and prevention of mental illness. There is ongoing research in clinical psychiatry that aims to improve our understanding of mental illness and develop more effective treatments, Precision psychiatry is an approach that aims to personalize mental health treatment based on an individual's unique genetic, biological, and environmental factors. Researchers are exploring the use of biomarkers and genetic testing to better understand mental illness and develop more targeted treatments. This sessions will covers a wide range of topics related to mental health and illness, and there are many other areas that could be explored as well.
- Track 14-1 Mood disorders
- Track 14-2 Anxiety disorders
- Track 14-3 Psychotic disorders
- Track 14-4 Personality disorders
- Track 14-5 Substance abuse disorders
Geriatric psychiatry, also known as geropsychiatry, is a branch of psychiatry that focuses on the mental health care of older adults. It addresses the unique mental health needs and challenges that arise in later life, such as cognitive changes, physical health issues, and social isolation. Recent research in geriatric psychiatry has focused on improving the diagnosis and treatment of mental health conditions in older adults, as well as promoting mental wellness and quality of life in later life. This sessions will cover a critical for promoting better mental health outcomes for older adults, improving their quality of life, and providing valuable support for their families and caregivers.
- Track 15-1 Cognitive disorders
- Track 15-2 Mood disorders
- Track 15-3 Psychotic disorders
- Track 15-4 Sleep disorders
- Track 15-5 Substance abuse
Forensic psychiatry is a specialized field of psychiatry that focuses on the intersection between mental health and the law. Recent research study examined the accuracy of risk assessment tools used by forensic psychiatrists to predict future violent behavior in patients. The study found that some commonly used tools were less accurate than others, highlighting the need for ongoing refinement and improvement in this area. In this session, we can discuss how forensic psychiatry relates to the treatment of individuals who have mental health issues and who are involved in legal matters.
- Track 16-1 Pervasive Developmental Disorder
- Track 16-2 Child and Adolescent Psychiatry
- Track 16-3 Intellectual Disability
- Track 16-4 Learning Disorder
- Track 16-5 Mental Health
Psychiatric treatment involves the diagnosis and management of mental health conditions through a variety of interventions. These interventions can include psychotherapy, medication management, and other forms of supportive care. With the rise of technology, there has been increasing interest in the use of digital interventions, such as mobile apps and online therapy, in the treatment of mental health conditions. Recent research has shown that these interventions can be effective in improving symptoms and increasing access to care. In this session will cover a Investigating the effectiveness of mindfulness-based cognitive therapy in reducing symptoms of anxiety and depression in adults. Analyzing the factors that impact the patient experience of ECT, and exploring ways to optimize the therapeutic benefits while minimizing negative side effects.
- Track 17-1 Psychotherapy
- Track 17-2 Electroconvulsive therapy (ECT)
- Track 17-3 Transcranial magnetic stimulation (TMS)
- Track 17-4 Dual diagnosis treatment
- Track 17-5 Psychiatric rehabilitation
Psychiatric symptoms are a wide-ranging set of experiences that can be indicative of a variety of mental health conditions. Research published in the Journal of Clinical Psychiatry in 2020 found that individuals with depression and anxiety had a significantly increased risk of developing Alzheimer's disease later in life, compared to those without these psychiatric symptoms. This sessions will cover a investigating the effectiveness of mindfulness-based interventions in reducing symptoms of depression, anxiety, and sleep disorders in a clinical population.
- Track 18-1 Depression
- Track 18-2 Psychosis
- Track 18-3 Personality disorders
- Track 18-4 Eating disorders
- Track 18-5 Sleep disorders
Psychiatric disorders refer to a broad range of mental health conditions that affect an individual's thoughts, emotions, and behaviors. These disorders can range from mild to severe and can have a significant impact on an individual's daily functioning and quality of life. This sessions will cover a advances in brain imaging technology have allowed researchers to better understand the neurobiological basis of psychiatric disorders. recent research in psychiatry has led to new treatments and a better understanding of the underlying mechanisms of psychiatric disorders.
- Track 19-1 Neurocognitive disorders
- Track 19-2 Treatment adherence
- Track 19-3 Stigma and discrimination
- Track 19-4 Comorbidity
- Track 19-5 Diagnosis and assessment
- Track 19-6 Mood disorder
Psychological trauma refers to the emotional, cognitive, and physical responses that occur after an individual experiences a distressing or life-threatening event. Trauma can have a profound impact on an individual's mental health, leading to symptoms such as anxiety, depression, post-traumatic stress disorder (PTSD), and other mental health condition recent research on psychological trauma has helped to deepen our understanding of the impact of trauma on mental health and has led to the development of more effective interventions and treatments for trauma-related conditions. In this session will cover focus on the impact of trauma on the brain and nervous system. It could explore research on the stress response system, the impact of trauma on brain function and structure, and how these biological changes can contribute to mental health conditions.
- Track 20-1 Neurobiology of trauma
- Track 20-2 Adverse childhood experiences (ACEs)
- Track 20-3 Trauma-informed care
- Track 20-4 Cultural considerations in trauma
- Track 20-5 Resilience and post-traumatic growth
Psychological medicine practitioners typically include psychiatrists, psychologists, and other mental health professional psychological medicine has seen significant advancements in recent years, particularly in the areas of neuroimaging and molecular genetics. These advances have helped to improve the understanding of the biological and environmental factors that contribute to mental illness and have led to the development of new treatments and therapies for a variety of mental health conditions. In this sessions will cover a treatments have traditionally been considered psychiatric, they are also beneficial in patients without overt psychiatric disorders.
- Track 21-1 Effects of social media addiction on mental health
- Track 21-2 Psychopharmacology
- Track 21-3 Psychodynamic therapy
- Track 21-4 Psychotherapy techniques
- Track 21-5 Psychoanalysis
- Track 21-6 Psychiatric disorder
Psychotherapy, also known as talk therapy, is a form of treatment for mental illnesses that involves talking with a mental health professional. The goal of psychotherapy is to improve a person's mental health and well-being by helping them understand and manage their thoughts, emotions, and behaviors. There is ongoing research in psychotherapy that aims to improve the effectiveness and accessibility of mental health treatment. This sessions will going conduct a exact focus of psychotherapy sessions will vary depending on the individual and their specific mental health needs.
- Track 22-1 Cognitive-behavioral therapy (CBT)
- Track 22-2 Psychodynamic therapy
- Track 22-3 Humanistic therapy
- Track 22-4 Dialectical behavior therapy (DBT)
- Track 22-5 Interpersonal therapy
Pharmacology is the study of how drugs interact with living organisms, including humans. It involves the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body, as well as the effects that drugs have on various physiological processes. Recent research in pharmacology, as the field continues to advance, new discoveries and breakthroughs are likely to emerge, leading to more effective and safer treatments for a range of diseases and conditions. This sessions will cover a these topics are all important areas of study within pharmacology, and are essential for understanding the safety, efficacy, and clinical applications of drugs and we can develop a more comprehensive understanding of how drugs work, how they can be used safely and effectively, and how they can be optimized for individual patients.
- Track 23-1 Pharmacokinetics
- Track 23-2 Pharmacodynamics
- Track 23-3 Pharmacogenomics
- Track 23-4 Toxicology
- Track 23-5 Pharmacoeconomics